Cholesterol-induced hepatic inflammation does not contribute to the development of insulin resistance in male LDL receptor knockout mice

Atherosclerosis

Volumn 232, Issue 2, 2014, Pages 390-396

  Funke, Anouk ^a   Schreurs, Marijke ^a   Aparicio Vergara, Marcela ^a   Sheedfar, Fareeba ^a   Gruben, Nanda ^a   Kloosterhuis, Niels J ^a   Shiri Sverdlov, Ronit ^b   Groen, Albert K ^a   van de Sluis, Bart ^a   Hofker, Marten H ^a   Koonen, Debby P Y ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cholesterol; Inflammation; Insulin resistance; Kupffer cells; LDLR; Liver; Obesity

Indexed keywords

CHOLESTEROL; GLUCOSE; INSULIN; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG INDUCED DISEASE; EXPERIMENTAL HEPATITIS; GLUCOSE BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; KNOCKOUT MOUSE; KUPFFER CELL; LIPID DIET; LIPOPROTEIN DEFICIENCY; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CHOLESTEROL; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELLS; LDLR; LIVER; OBESITY;

ANIMAL FEED; ANIMALS; CHOLESTEROL; DIET; DIETARY FATS; GLUCOSE TOLERANCE TEST; HEPATOCYTES; INFLAMMATION; INSULIN; INSULIN RESISTANCE; KUPFFER CELLS; LIVER; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, LDL;

EID: 84892872444     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2013.11.074     Document Type: Article

References (33)

1. Gregor M.F., Hotamisligil G.S. Inflammatory mechanisms in obesity. Annu Rev Immunol 2011, 29:415-445.
2. Tilg H., Moschen A.R. Insulin resistance, inflammation, and non-alcoholic fatty liver disease. Trends Endocrinol Metab 2008, 19:371-379.
3. Cai D., Yuan M., Frantz D.F., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 2005, 11:183-190.
4. Lee Y.S., Li P., Huh J.Y., et al. Inflammation is necessary for long-term but not short-term high-fat diet-induced insulin resistance. Diabetes 2011, 60:2474-2483.
5. Arkan M.C., Hevener A.L., Greten F.R., et al. IKK-beta links inflammation to obesity-induced insulin resistance. Nat Med 2005, 11:191-198.
6. Odegaard J.I., Ricardo-Gonzalez R.R., Red E.A., et al. Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance. Cell Metab 2008, 7:496-507.
7. Aparicio-Vergara M., Hommelberg P.P., Schreurs M., et al. TNF receptor 1 gain-of-function mutation aggravates non-alcoholic fatty liver disease but does not cause insulin resistance in mice. Hepatology 2012, e26046.
8. Clementi A.H., Gaudy A.M., van Rooijen N., Pierce R.H., Mooney R.A. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling. Biochim Biophys Acta 2009, 1792:1062-1072.
9. Hosoi T., Yokoyama S., Matsuo S., Akira S., Ozawa K. Myeloid differentiation factor 88 (MyD88)-deficiency increases risk of diabetes in mice. PLoS ONE 2010, 5:e12537.
10. Jornayvaz F.R., Birkenfeld A.L., Jurczak M.J., et al. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2. Proc Natl Acad Sci U S A 2011, 108:5748-5752.
11. Schreyer S.A., Chua S.C., LeBoeuf R.C. Obesity and diabetes in TNF-alpha receptor-deficient mice. JClin Invest 1998, 102:402-411.
12. Olefsky J.M., Glass C.K. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
13. Huang W., Metlakunta A., Dedousis N., et al. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance. Diabetes 2010, 59:347-357.
14. Neyrinck A.M., Cani P.D., Dewulf E.M., De Backer F., Bindels L.B., Delzenne N.M. Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. Biochem Biophys Res Commun 2009, 385:351-356.
15. Stienstra R., Saudale F., Duval C., et al. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity. Hepatology 2010, 51:511-522.
16. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. JClin Invest 1993, 92:883-893.
17. Schreyer S.A., Vick C., Lystig T.C., Mystkowski P., LeBoeuf R.C. LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice. Am J Physiol Endocrinol Metab 2002, 282:E207-E214.
18. Subramanian S., Han C.Y., Chiba T., et al. Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2008, 28:685-691.
19. Bieghs V., van Gorp P.J., Wouters K., et al. LDL receptor knock-out mice are a physiological model particularly vulnerable to study the onset of inflammation in non-alcoholic fatty liver disease. PLoS ONE 2012, 7:e30668.
20. Subramanian S., Goodspeed L., Wang S., et al. Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice. JLipid Res 2011, 52:1626-1635.
21. Wouters K., van Gorp P.J., Bieghs V., et al. Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis. Hepatology 2008, 48:474-486.
22. Collins S., Martin T.L., Surwit R.S., Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav 2004, 81:243-248.
23. Koonen D.P., Sung M.M., Kao C.K., et al. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes 2010, 59:1366-1375.
24. Zabel B.A., Ohyama T., Zuniga L., et al. Chemokine-like receptor 1 expression by macrophages invivo: regulation by TGF-beta and TLR ligands. Exp Hematol 2006, 34:1106-1114.
25. Maeda S., Kamata H., Luo J.L., Leffert H., Karin M. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005, 121:977-990.
26. Brown J.M., Betters J.L., Lord C., et al. CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance. JLipid Res 2010, 51:3306-3315.
27. Kozlitina J., Boerwinkle E., Cohen J.C., Hobbs H.H. Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance. Hepatology 2011, 53:467-474.
28. Minehira K., Young S.G., Villanueva C.J., et al. Blocking VLDL secretion causes hepatic steatosis but does not affect peripheral lipid stores or insulin sensitivity in mice. JLipid Res 2008, 49:2038-2044.
29. Monetti M., Levin M.C., Watt M.J., et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007, 6:69-78.
30. Eguchi K., Manabe I., Oishi-Tanaka Y., et al. Saturated fatty acid and TLR signaling link beta cell dysfunction and islet inflammation. Cell Metab 2012, 15:518-533.
31. Ehses J.A., Perren A., Eppler E., et al. Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 2007, 56:2356-2370.
32. Hao M., Head W.S., Gunawardana S.C., Hasty A.H., Piston D.W. Direct effect of cholesterol on insulin secretion: a novel mechanism for pancreatic beta-cell dysfunction. Diabetes 2007, 56:2328-2338.
33. Bonfleur M.L., Vanzela E.C., Ribeiro R.A., et al. Primary hypercholesterolaemia impairs glucose homeostasis and insulin secretion in low-density lipoprotein receptor knockout mice independently of high-fat diet and obesity. Biochim Biophys Acta 2010, 1801:183-190.